Xaar PLC
24 May 2007
Xaar plc ('the Company')
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
On 22 May 2007 Gregory Lockett exercised 100,000 options with an exercise price
of 84p and sold 100,000 shares at 248p per share. On 29 March 2007 Mr Lockett
sold 26,084 shares in the company at 225p per share. Following these
transactions Mr Lockett holds no shares in the company.
The Company also received a notification on 24 May 2007 from Barclays Private
Bank & Trust Limited as trustees of the Xaar Plc Employee Benefit Trust
informing it that the trustees purchased 105,000 ordinary shares on 22 May 2007
at 248p per share.
The Trustees total interest is currently 1,517,004 shares representing 2.4% of
the Company's issued ordinary share capital. The announcement is made due to the
potential interest of the Directors and persons discharging managerial
responsibility.
Andrew Taylor
Deputy Finance Director & Company Secretary
Xaar plc
Phone: +44 (0)1223 423 663
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.